FDA Approved: IPRATROPIUM BROMIDE — Original Application (Lupin Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approves Lupin Pharmaceuticals' original application for ipratropium bromide, a generic formulation of the anticholinergic bronchodilator.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease
• Common Cold
• Rhinitis

Drugs mentioned

• IPRATROPIUM BROMIDE (IPRATROPIUM BROMIDE)

Snippet

ORIG AP for IPRATROPIUM BROMIDE (IPRATROPIUM BROMIDE)